STAGE III SINONASAL CANCER AJCC V8
Clinical trials for STAGE III SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink tumors before surgery, possibly sparing organs
Disease control Recruiting nowThis study is testing if adding an immunotherapy drug called cemiplimab to standard chemotherapy before surgery works better than chemotherapy alone for a type of head and neck cancer. It aims to see if the combination can better shrink tumors, improve survival, and potentially h…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug joins fight against tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing whether adding a new oral drug called ipatasertib to the standard treatment of chemotherapy plus radiation is safe and more effective for people with locally advanced head and neck cancer. The main goal is to find the safest and most effective do…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC